User profiles for Benjamin Skov Kaas-Hansen

Benjamin Skov Kaas-Hansen (MD, MSc, PhD)

Postdoctoral Research Fellow, Dept. of Intensive Care, Copenhagen University Hospital
Verified email at ku.dk
Cited by 902

Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: a retrospective study of high-frequency data in electronic …

…, AB Nielsen, AP Nielsen, BS Kaas-Hansen… - The Lancet Digital …, 2020 - thelancet.com
Background Many mortality prediction models have been developed for patients in intensive
care units (ICUs); most are based on data available at ICU admission. We investigated …

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

…, L Hester, G Hripcsak, BS Kaas-Hansen… - The Lancet …, 2020 - thelancet.com
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

…, A Perner, M Helleberg, BS Kaas-Hansen… - Scientific reports, 2021 - nature.com
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different stages …

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

…, H Jeon, Y Jing, CY Jung, BS Kaas-Hansen… - Nature …, 2020 - nature.com
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …

Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network

…, G Hripcsak, BS Kaas-Hansen… - BMC Medical Research …, 2022 - Springer
Background We investigated whether we could use influenza data to develop prediction
models for COVID-19 to increase the speed at which prediction models can reliably be …

Discrete-time survival analysis in the critically ill: a deep learning approach using heterogeneous data

HC Thorsen-Meyer, D Placido, BS Kaas-Hansen… - NPJ digital …, 2022 - nature.com
Prediction of survival for patients in intensive care units (ICUs) has been subject to intense
research. However, no models exist that embrace the multiverse of data in ICUs. It is an open …

Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care …

…, M Leone, BS Kaas-Hansen… - Critical Care …, 2024 - journals.lww.com
OBJECTIVES: To provide guidance on the reporting of norepinephrine formulation labeling,
reporting in publications, and use in clinical practice. DESIGN: Review and task force …

[HTML][HTML] An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials

A Granholm, BS Kaas-Hansen, T Lange… - Journal of clinical …, 2023 - Elsevier
Background and Objectives Adaptive features may increase flexibility and efficiency of
clinical trials, and improve participants’ chances of being allocated to better interventions. Our …

Use of days alive without life support and similar count outcomes in randomised clinical trials–an overview and comparison of methodological choices and analysis …

A Granholm, BS Kaas-Hansen, T Lange… - BMC Medical Research …, 2023 - Springer
Background Days alive without life support (DAWOLS) and similar outcomes that seek to
summarise mortality and non-mortality experiences are increasingly used in critical care …

Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international …

…, V Huser, H Jeon, Y Jing, CY Jung, BS Kaas-Hansen… - medRxiv, 2020 - medrxiv.org
Background In this study we phenotyped individuals hospitalised with coronavirus disease
2019 (COVID-19) in depth, summarising entire medical histories, including medications, as …